Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Boku S, Satake H, Ohta T, Mitani S, Kawakami K, Suzuki Y, Matsumoto T, Terazawa T, Yamazaki E, Hasegawa H, Ikoma T, Uemura M, Yamaguchi T, Naito A, Ishizuka Y, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Tsujinaka T, Kato T, Satoh T, Kagawa Y. Boku S, et al. Among authors: shimokawa t. Future Oncol. 2022 Dec;18(38):4153-4160. doi: 10.2217/fon-2022-0949. Epub 2022 Dec 8. Future Oncol. 2022. PMID: 36475784 Free article.
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K, Nakane Y, Kogire M, Fujitani K, Kimura Y, Imamura H, Tamura S, Okano S, Kwon AH, Kurokawa Y, Shimokawa T, Takiuchi H, Tsujinaka T, Furukawa H. Inoue K, et al. Among authors: shimokawa t. Eur J Surg Oncol. 2012 Feb;38(2):143-9. doi: 10.1016/j.ejso.2011.11.009. Epub 2011 Dec 9. Eur J Surg Oncol. 2012. PMID: 22154885 Clinical Trial.
Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer.
Fujitani K, Tsujinaka T, Fujita J, Miyashiro I, Imamura H, Kimura Y, Kobayashi K, Kurokawa Y, Shimokawa T, Furukawa H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Fujitani K, et al. Among authors: shimokawa t. Br J Surg. 2012 May;99(5):621-9. doi: 10.1002/bjs.8706. Epub 2012 Feb 24. Br J Surg. 2012. PMID: 22367794 Clinical Trial.
A Phase I/II trial of radiotherapy concurrent with TS-1 plus cisplatin in patients with clinically resectable type 4 or large type 3 gastric cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group OGSG1205.
Imano M, Furukawa H, Yokokawa M, Nishimura Y, Kurokawa Y, Satoh T, Sakai D, Yasuda T, Imamoto H, Tujinaka T, Shimokawa T, Shiozaki H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Imano M, et al. Among authors: shimokawa t. Jpn J Clin Oncol. 2013 Apr;43(4):431-5. doi: 10.1093/jjco/hys239. Epub 2013 Feb 26. Jpn J Clin Oncol. 2013. PMID: 23447812 Clinical Trial.
Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy.
Fujitani K, Tamura S, Kimura Y, Tsuji T, Matsuyama J, Iijima S, Imamura H, Inoue K, Kobayashi K, Kurokawa Y, Shimokawa T, Tsujinaka T, Furukawa H. Fujitani K, et al. Among authors: shimokawa t. Gastric Cancer. 2014 Apr;17(2):348-53. doi: 10.1007/s10120-013-0273-7. Epub 2013 Jun 5. Gastric Cancer. 2014. PMID: 23736741 Clinical Trial.
755 results